Acute Severe Migraine Treatment via Telehealth
For this patient with severe migraine presenting with nausea, photophobia, and pulsating headache worsened by movement, prescribe sumatriptan 50-100 mg PLUS naproxen sodium 500 mg to be taken immediately, with instructions to treat early in future attacks and strict limitation to no more than 2 days per week to prevent medication-overuse headache. 1
Immediate Treatment Strategy
Combination therapy with triptan plus NSAID is superior to either agent alone and represents the strongest evidence-based recommendation for moderate to severe migraine. 1 This combination provides 130 more patients per 1000 achieving sustained pain relief at 48 hours compared to monotherapy. 1
Specific Prescribing Instructions
- Sumatriptan 50-100 mg orally at migraine onset - doses of 50 mg and 100 mg provide greater effect than 25 mg, though 100 mg may not provide greater effect than 50 mg. 2
- Naproxen sodium 500-825 mg taken simultaneously with the triptan for synergistic effect. 1
- If headache persists after 2 hours, a second dose of sumatriptan may be taken, but must wait at least 2 hours between doses with maximum 200 mg in 24 hours. 2
- Treat early in the attack while pain is still mild for maximum effectiveness - this is critical for optimal response. 3, 1
Adjunctive Antiemetic Therapy
Given the prominent nausea, add metoclopramide 10 mg orally to be taken 20-30 minutes before the triptan-NSAID combination. 1 Metoclopramide provides direct analgesic effects through central dopamine receptor antagonism beyond its antiemetic properties, and its prokinetic effects enhance absorption of co-administered medications. 1
Critical Frequency Limitation
Strictly limit all acute migraine medications to no more than 2 days per week (10 days per month) to prevent medication-overuse headache (MOH). 1 MOH paradoxically increases headache frequency and can lead to daily headaches, creating a vicious cycle. 3 If the patient requires acute treatment more than twice weekly, preventive therapy must be initiated immediately. 1
Addressing Modifiable Triggers
Counsel the patient on lifestyle modifications targeting their identified triggers: 3
- Regular sleep schedule - irregular sleep is a major modifiable trigger that must be addressed. 3
- Consistent meal timing - skipping meals or irregular eating patterns trigger attacks. 3
- Stress management techniques including relaxation training, meditative therapy (abdominal breathing exercises), progressive muscle relaxation, or cognitive-behavioral therapy. 3
- Maintain a headache diary to track attack frequency, triggers, and medication use - this provides a helpful tool for gauging improvement and identifying medication overuse. 3
When to Escalate Treatment
If sumatriptan fails after 2-3 headache episodes, try a different triptan - failure of one triptan does not predict failure of others. 1 Alternative options include:
- Rizatriptan 10 mg - reaches peak concentration in 60-90 minutes, making it the fastest oral triptan. 1
- Eletriptan 40 mg or zolmitriptan 2.5-5 mg - reportedly more effective with fewer adverse reactions than sumatriptan. 1
- Subcutaneous sumatriptan 6 mg - provides highest efficacy with onset within 15 minutes if oral formulations fail. 1
If all triptans fail after adequate trials, escalate to CGRP antagonists (gepants) such as ubrogepant 50-100 mg or rimegepant, which have no vasoconstriction and are safe for patients with cardiovascular contraindications. 1
Indications for Preventive Therapy
Initiate preventive therapy if: 3
- Two or more attacks per month producing disability lasting 3+ days. 3
- Use of acute medications more than twice per week. 1
- This current episode being "more severe than previous ones" suggests possible progression toward chronic migraine. 3
First-line preventive options include propranolol 80-240 mg/day, topiramate, or amitriptyline 30-150 mg/day (particularly useful for mixed migraine and tension-type headache). 3 Preventive therapy requires 2-3 months to assess efficacy. 4
Contraindications to Screen For
Before prescribing triptans, confirm the patient does NOT have: 1
- Ischemic heart disease or previous myocardial infarction
- Uncontrolled hypertension
- Cerebrovascular disease
- Vasospastic coronary disease
NSAIDs should be avoided if: 1
- Renal impairment (creatinine clearance <30 mL/min)
- Active GI bleeding or peptic ulcer disease
- Aspirin/NSAID-induced asthma
Work Absence Documentation
Provide medical certificate for work absence given the severity of symptoms (nausea, photophobia, pulsating pain worsened by movement) which are disabling and prevent normal function. 3 Migraine causes significant impairment in quality of life and work performance. 3
Critical Pitfall to Avoid
Do not allow the patient to increase frequency of acute medication use in response to treatment failure - this creates the vicious cycle of MOH. 1 Instead, transition to preventive therapy while optimizing the acute treatment strategy. 1 The patient must understand that migraine is a neurological disorder with a biological basis requiring a multimodal approach, and expectations for symptom resolution should be realistic as recovery may be gradual. 3